Abstract

In this study, we determined the gene expression profiles of bone marrow‐derived cell fractions, obtained from normal subjects and Chronic Myeloid Leukemia (CML) patients, that were highly enriched for hematopoietic stem (HSCs) and progenitor (HPCs) cells. Our results indicate that the profiles of CML HSCs and HPCs were closer to that of normal progenitors, whereas normal HSCs showed the most different expression profile of all. We found that the expression profiles of HSCs and HPCs from CML marrow were closer to each other than those of HSCs and HPCs from normal marrow. The major biologic processes dysregulated in CML cells included DNA repair, cell cycle, chromosome condensation, cell adhesion, and the immune response. We also determined the genomic changes in both normal and CML progenitor cells under culture conditions, and found that several genes involved in cell cycle, steroid biosynthesis, and chromosome segregation were upregulated, whereas genes involved in transcription regulation and apoptosis were downregulated. Interestingly, these changes were the same, regardless of the addition of Imatinib (IM) to the culture. Finally, we identified three genes—PIEZO2, RXFP1, and MAMDC2‐ that are preferentially expressed by CML primitive cells and that encode for cell membrane proteins; thus, they could be used as biomarkers for CML stem cells.

Highlights

  • Chronic myeloid leukemia (CML) is a neoplastic hematological disease characterized by the abnormal overproduction and accumulation, both in blood and bone marrow, of myeloid cells

  • We performed a global comparison of the gene expression profiles from the four cell populations analyzed, that is, CD34+ CD38−Lin− and CD34+ CD38+Lin− cells from both, hematologically normal subjects and CML patients

  • Among all human malignancies known to date, CML is arguably the best known in terms of its biology

Read more

Summary

Introduction

Chronic myeloid leukemia (CML) is a neoplastic hematological disease characterized by the abnormal overproduction and accumulation, both in blood and bone marrow, of myeloid cells.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call